Trial intelligence / Profile preview

Dexmedetomidine for Prevention of Acute Kidney Injury in Sepsis

TCTR20230925003Completed

Sponsor
N/A
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Trial of dexmedetomidine in sepsis and acute kidney failure (AKF), sponsored by N/A. Started Dec 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

sepsisacute kidney failure (AKF)

Beyond the preview

Go deeper on TCTR20230925003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230925003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call